Silence Therapeutics (SLN) Goodwill & Intangibles (2018 - 2026)

Silence Therapeutics has reported Goodwill & Intangibles for 9 years, with the latest figure at $10.6 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 2.97% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (down 2.97% YoY) and the FY2025 annual result came in at $10.9 million, up 12.42% from the prior year.
• Goodwill & Intangibles eased to $10.6 million in Q1 2026 per SLN's latest filing, from $10.9 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $10.9 million in Q2 2025 and troughed at $9.4 million in Q3 2024.
• A 5-year average of $10.3 million and a median of $10.3 million in 2026 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles decreased 6.15% in 2022, then climbed 16.18% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $9.8 million in 2022, then rose by 3.21% to $10.1 million in 2023, then retreated by 3.76% to $9.7 million in 2024, then advanced by 12.42% to $10.9 million in 2025, then dropped by 2.78% to $10.6 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $10.6 million, $10.9 million, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.